$IMVT
Immunovant, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
IMVT chart
What traders are saying about $IMVT
Latest postsImmunovant, Inc. news
- Form 4 Immunovant Inc: Jay S. Stout (CTO) For: 21 October By Investing.com
Investing.com South Africa ·
- Form 4 Immunovant Inc: Jay S. Stout (CTO) For: 21 October
Investing.com Canada ·
- Immunovant CTO Jay Stout sells $75,099 in shares
Investing.com ·
- Immunovant, Inc. Estimates – NASDAQ:IMVT
TradingView ·
- Form 4 Roivant Sciences Ltd.: Eric Venker (President & Immunovant CEO) For: 20 October
Investing.com India ·
- How Immunovant Inc. (IMVT) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Immunovant, Inc. (IMVT) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Immunovant to report Q2 2026 financial results and business update on Nov 9
Pluang ·
- Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Yahoo Finance ·
- Immunovant (IMVT) Stock Looks Stretched On Book Value Alone
Yahoo Finance ·
- IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class
stocktwits.com ·
- Why Immunovant (IMVT) Is Down 10.3% After Halting IMVT-1402 Development in Cutaneous Lupus – And What's Next
Yahoo Finance ·
Immunovant, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$505.6M | -$413.8M | -$259.3M | -$211.0M |
| Diluted EPS | $-2.77 | $-2.73 | $-1.88 | $-1.71 |
| Total assets (year end) | $1.05B | $420.9M | $711.4M | $456.2M |
| Cash and equivalents (year end) | $994.5M | $374.7M | $690.9M | $432.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immunovant, Inc.
- Ticker
- IMVT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 1764013
- Former names
- Health Sciences Acquisitions Corp
Frequently asked questions
What exchange is Immunovant, Inc. listed on?
Immunovant, Inc. trades on the Nasdaq under the ticker symbol IMVT.
What industry is Immunovant, Inc. in?
Immunovant, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Immunovant, Inc. headquartered?
Immunovant, Inc.'s business address on file with the SEC is in Durham, NC.
When does Immunovant, Inc.'s fiscal year end?
Immunovant, Inc.'s fiscal year ends on March 31.